Multiple sclerosis
We’re all in this for good.
- help each other live better and uncover the best ways to manage your health today
- help researchers shorten the path to new treatments tomorrow
How much good can your data do? A whole lot, as member Jackie explains in this video.
What is multiple sclerosis?
Multiple sclerosis (MS) is an autoimmune disorder characterized by destruction of myelin in the central nervous system. MS symptoms may include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction.
Common symptoms reported by people with multiple sclerosis
Common symptoms
How bad it is
What people are taking for it
Common symptom
Numbness and tingling with pins and needles
How bad it is
What people are taking for it
Common symptom
Coughing while eating
How bad it is
What people are taking for it
Nothing reported yet
Reports may be affected by other conditions and/or medication side effects. We ask about general symptoms (anxious mood, depressed mood, fatigue, pain, and stress) regardless of condition.
Last updated:
Treatments taken by people for multiple sclerosis
Treatment name(s)
Type
How many have tried
Tried for
Data from patients with multiple sclerosis, who have ever reported treatments, ordered by their reporting frequency during the last 5 years.
Last updated:
Compare treatments taken by people with multiple sclerosis
Treatment name(s)
Perceived effectiveness
Side effects
Total evaluations
Tried for
Perceived effectiveness
for multiple sclerosis (81 evaluations)
Total evaluations
81
Tried for
multiple sclerosis
(165)
Perceived effectiveness
for multiple sclerosis (47 evaluations)
Total evaluations
47
Tried for
multiple sclerosis
(54)
Perceived effectiveness
for multiple sclerosis (32 evaluations)
Total evaluations
32
Tried for
multiple sclerosis
(54)
Perceived effectiveness
for multiple sclerosis (29 evaluations)
Total evaluations
29
Tried for
multiple sclerosis
(47)
Perceived effectiveness
for multiple sclerosis (16 evaluations)
Total evaluations
17
Tried for
multiple sclerosis
(27)
Perceived effectiveness
for multiple sclerosis (24 evaluations)
Total evaluations
24
Tried for
multiple sclerosis
(19)
Perceived effectiveness
for multiple sclerosis (8 evaluations)
Side effects
chronic fatigue
indigestion
Total evaluations
8
Tried for
multiple sclerosis
(18)
Perceived effectiveness
for multiple sclerosis (7 evaluations)
Total evaluations
7
Tried for
multiple sclerosis
(14)
Perceived effectiveness
for multiple sclerosis (11 evaluations)
Total evaluations
11
Tried for
multiple sclerosis
(6)
Perceived effectiveness
for multiple sclerosis (3 evaluations)
Side effects
constant tiredness
low grade fever
Total evaluations
3
Tried for
multiple sclerosis
(6)
- Major
- Moderate
- Slight
- None
- Can't tell
- Severe
- Moderate
- Mild
- None
Data from patients with multiple sclerosis, who have ever reported treatments, ordered by their reporting frequency during the last 5 years.
Last updated:
Who has multiple sclerosis on PatientsLikeMe?
- 108 new patients joined this month
- 70831 say MS is their primary condition
| Age | Proportion | # of patients |
|---|---|---|
| <20 | 28 | |
| 20s | 738 | |
| 30s | 5351 | |
| 40s | 14317 | |
| 50s | 20570 | |
| 60s | 15079 | |
| 70+ | 5133 |
| Age at first symptom | Proportion | # of patients |
|---|---|---|
| 0-19 years | 2894 | |
| 20-29 years | 9459 | |
| 30-39 years | 9942 | |
| 40-49 years | 6070 | |
| 50-59 years | 1555 | |
| 60-69 years | 155 | |
| 70+ years | 18 |
Distribution of sex
| Sex | Proportion | # of patients |
|---|---|---|
| Male | 11301 | |
| Female | 50586 |
| Condition Types | Proportion | # of patients |
|---|---|---|
| Primary progressive multiple sclerosis | 4770 | |
| Relapsing-remitting multiple sclerosis | 39657 | |
| Secondary progressive multiple sclerosis | 6042 |
| Diagnosis status | Proportion | # of patients |
|---|---|---|
| Diagnosed | 33711 | |
| Not Diagnosed | 1348 |
These charts show data from MS patients who have completed their condition history
Last updated: